Member Bulletin Board

Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response

By California Life Sciences Member: XPose Therapeutics

Cancer will directly affect the lives of over one-third of the population. The DNA Damage Response (DDR) is an intricate system involving damage recognition, cell cycle regulation, DNA repair, and ultimately cell fate determination, playing a central role in cancer etiology and therapy. Read more…

CHO Plus Announces Acceptance Into BLUE KNIGHT™

By California Life Sciences Member: CHO Plus

CHO Plus, an early-stage innovation company developing technology to dramatically increase the productivity of cells used to manufacture therapeutic proteins and viruses, announced today that it has been accepted into Blue Knight, and will receive funding to support their JLABS @ South San Francisco residency. Read more…

Promaxo Announces Sale of In-Office MRI to Advanced Urology Medical Offices

By California Life Sciences Member: Promaxo

Promaxo, Inc., a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Advanced Urology Medical Offices (Advanced Urology). FDA cleared for in-office use, the Company’s single-sided MRI system with AI based imaging empowers practices and hospitals to accurately and seamlessly guide prostate interventions under the Promaxo scanner. Read more…

Explora BioLabs Opens New Facility in San Diego, Calif.

By California Life Sciences Member: Explora Biolabs

Explora BioLabs, a national provider of industry-leading preclinical vivarium research space and management services based in San Diego, opened a new facility here on August 23, 2021. Read more…

Carnegie Mellon University and Emerald Cloud Lab to Build World’s First University Cloud Lab

By California Life Sciences Member: Emerald Cloud Lab

Carnegie Mellon University and Emerald Cloud Lab (ECL) have entered into a partnership to build the world’s first cloud lab in an academic setting. The remote-controlled lab will provide a universal platform for artificial intelligence-driven experimentation and revolutionize how academic laboratory research and education are done. Read more…

R&D Tax Credits and the Orphan Drug Credit: Key Differences and Benefits

By California Life Sciences Member: Moss Adams

Two of the most lucrative tax credits available to life sciences companies are the R&D credit and orphan drug credit (ODC). Both incentives provide companies with immediate or future tax benefits intended to reduce the cost of their development operations. Read more…

Micronoma, University of New South Wales Tackle Liver Cancer with $4 Million Grant

By California Life Sciences Member: Micronoma

Micronoma, the first cancer detection company to harness tumor-associated circulating microbial biomarkers to diagnose cancer at an early stage via microbiome-driven liquid biopsy technology, today announced a collaboration with the University of New South Wales, Sydney for a $4 million grant from the Australian Government to fund research into hepatocellular carcinoma, the most common type of primary liver cancer. Read more…

Public Markets Reflect Long-Term Growth Opportunity for Life Sciences Companies

By California Life Sciences Member: RSM 

Don’t miss out on the latest life sciences insights from RSM Senior Analysts Adam Lohr and Steve Kemler. In this edition of The Real Economy: Industry Outlook, they share data-driven insights on market trends and emerging issues facing life sciences companies. Read more…

What is Low-Volume, High-Complexity Manufacturing?

By California Life Sciences Member: Goddard

One of the trickiest transitions within the product development process is when a product’s design is gearing up for manufacturing. It’s one thing to look at a design’s renderings or prototypes – but production is when things start to feel very real. One way to ease the transition to manufacturing is by partnering with a product developer that can also handle low-volume, high-complexity manufacturing. Read more…